ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2020
Cross-border spread of
Abstract read
In one paragraph
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Molecular characterization of carbapenem resistance and hypervirulence determinants of Klebsiella pneumoniae circulating in a tertiary hospital in Cyprus.Molecular biology reports · 2026Article
- Carbapenem-Resistant Enterobacterales (CRE) in Europe: Surveillance Challenges, Emerging Threats and Public Health Preparedness.Antibiotics (Basel, Switzerland) · 2026Review
- Molecular Characterisation and Descriptive Analysis of Carbapenemase-Producing Enterobacterales: Striking Epidemiological Changes.Antibiotics (Basel, Switzerland) · 2026Article
- Leveraging the global genomic epidemiology of carbapenemase-producingAntimicrobial agents and chemotherapy · 2026Article
- The potential effectiveness of far-UVC (222 nm) in preventing infections in long-term care facilities: a six-month nonrandomized controlled phase II trial.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2026Article
- The bacterial etiology and antimicrobial susceptibility of lower respiratory tract infections in Vietnam.Annals of clinical microbiology and antimicrobials · 2025Article
- Genomic Epidemiology of ESBL- and Carbapenemase-Producing Enterobacterales in a Spanish Hospital: Exploring the Clinical-Environmental Interface.Microorganisms · 2025Article
- From structured surveys to outbreak investigations: advancing genomic surveillance of carbapenem-resistant Enterobacterales within the European Antimicrobial Resistance Genes Surveillance Network.Frontiers in public health · 2025Article
- Comparison of Carbapenemases and Extended-Spectrum β-Lactamases and Resistance Phenotypes in Hospital- and Community-Acquired Isolates ofMicroorganisms · 2024Article
- Can probiotics trigger a paradigm shift for cleaning healthcare environments? A narrative review.Antimicrobial resistance and infection control · 2024Review
- Molecular Epidemiology and Antimicrobial Resistance of Extended-SpectrumVeterinary medicine international · 2024Article
- Impact and Diversity of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2023Article
- Various arrangements of mobile genetic elements among CC147 subpopulations of Klebsiella pneumoniae harboring blaJournal of biomedical science · 2023Article
- Widespread Detection of Yersiniabactin Gene Cluster and Its Encoding Integrative Conjugative Elements (ICEMicrobiology spectrum · 2023Article
- Long-read sequencing reveals genomic diversity and associated plasmid movement of carbapenemase-producing bacteria in a UK hospital over 6 years.Microbial genomics · 2023Article
- Nationwide, population-based observational study of the molecular epidemiology and temporal trend of carbapenemase-producing Enterobacterales in Norway, 2015 to 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023Observational
- Emergence and Spread of Enterobacterales with Multiple Carbapenemases after COVID-19 Pandemic.Pathogens (Basel, Switzerland) · 2023Article
- Ribosomal MLST nucleotide identity (rMLST-NI), a rapid bacterial species identification method: application toMicrobial genomics · 2022Article
- Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Catherine LuddenEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Felix LötschEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Erik AlmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Narender KumarDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Karin JohanssonEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Barbara AlbigerEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Te-Din HuangBelgian National Reference Center for Antibiotic-resistant Gram-negative bacilli, CHU UCL Namur, UCLouvain, Yvoir, Belgium.
Olivier DenisBelgian National Reference Center for Antibiotic-resistant Gram-negative bacilli, CHU UCL Namur, UCLouvain, Yvoir, Belgium.
Anette M HammerumDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Henrik HasmanDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Jari JalavaDepartment of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.
Kati RäisänenDepartment of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland.
Laurent DortetFrench National Reference Center for Antimicrobial Resistance, INSERM UMR 1184, Paris-Saclay University, Bicêtre hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.
Agnès B JoussetFrench National Reference Center for Antimicrobial Resistance, INSERM UMR 1184, Paris-Saclay University, Bicêtre hospital, Assistance Publique des Hôpitaux de Paris, Paris, France.
Sören GatermannNational Reference Centre for multidrug-resistant Gram-negative bacteria, Ruhr University Bochum, Bochum, Germany.
Sebastian HallerRobert Koch Institute, Department for Infectious Disease Epidemiology, Berlin, Germany.
Martin CormicanNational University of Ireland, Galway, Ireland.
Wendy BrennanNational University of Ireland, Galway, Ireland.
Maria Del GrossoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Monica MonacoDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Leo SchoulsInfectious Diseases Research, Diagnostics and Laboratory Surveillance, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Ørjan SamuelsenNorwegian National Advisory Unit on Detection of Antimicrobial Resistance, University Hospital of North Norway, Tromsø, Norway.
Mateja PiršInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Tjaša CerarInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Jésus Oteo-IglesiasLaboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Maria Pérez-VázquezLaboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones Relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
Karin SjöströmPublic Health Agency of Sweden, Stockholm, Sweden.
Petra EdquistPublic Health Agency of Sweden, Stockholm, Sweden.
Katie L HopkinsHealthcare Associated Infections and Antimicrobial Resistance Division, National Infection Service, Public Health England, London, United Kingdom.
Marc J StruelensEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Daniel PalmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Dominique L MonnetEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Anke KohlenbergEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.
Funding
Wellcome Trust 110243/Z/15/Z
Abstract
Analysis of sequencing data for 143
Indexed as
Disease OutbreaksAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsEmigration and ImmigrationHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase NDM-1beta-LactamasesCarbapenemscarbapenemasecarbapenem-resistant Enterobacteralescross-border importKlebsiella pneumoniaOXA-48, NDM-1surveillancewhole genome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.